CoChat

Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

FKBP51 is an important inhibitor of the glucocorticoid receptor (GR) signaling. High FKBP51 levels are associated to stress-related disorders, which are linked to GR resistance. SUMO conjugation to FKBP51 is necessary for FKBP51's inhibitory action on GR. The GR/FKBP51 pathway is target of antidepressant action. Thus we investigated if these drugs could inhibit FKBP51 SUMOylation and therefore restore GR activity. Screening cells using Ni 2+ affinity and in vitro SUMOylation assays revealed that tricyclic antidepressants- particularly clomipramine- inhibited FKBP51 SUMOylation. Our data show that clomipramine binds to FKBP51 inhibiting its interaction with PIAS4 and therefore hindering its SUMOylation. The inhibition of FKBP51 SUMOylation decreased its binding to Hsp90 and GR facilitating FKBP52 recruitment, and enhancing GR activity. Reduction of PIAS4 expression in rat primary astrocytes impaired FKBP51 interaction with GR, while clomipramine could no longer exert its inhibitory action. This mechanism was verified in vivo in mice treated with clomipramine. These results describe the action of antidepressants as repressors of FKBP51 SUMOylation as a molecular switch for restoring GR sensitivity, thereby providing new potential routes of antidepressant intervention.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41380-022-01491-0

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 87 · Cited by 17

Metadata

Authors
Budziñski, M. L., Sokn, C., Gobbini, R., Ugo, B., Antunica-Noguerol, M., Senin, S., Bajaj, T., Gassen, N. C., Rein, T., Schmidt, M. V., Binder, E. B., Arzt, E., & Liberman, A. C.
Affiliations
  • Max Planck Society (DE)
  • University of Bonn (DE)
  • Max Planck Institute of Psychiatry (DE)
Corresponding author
  • Arzt, Eduardo
  • Liberman, Ana C.
Venue
Molecular Psychiatry
Published
2022-03-08
Volume
27
Issue
5
Pages
2533-2545
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W4220857785
Cited by
17
References
87
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 5
FWCI
2.36
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • Agencia Nacional de Promoción Científica y Tecnológica, Argentina
  • Bundesministerium für Bildung und Forschung (01EE1401D)
  • “OptiMD” grant of the Federal Ministry of Education and Research Germany
  • Max Planck Society, Germany; University of Buenos Aires; CONICET; Agencia Nacional de Promoción Científica y Tecnológica, Argentina; and FOCEM-Mercosur
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
tricyclic antidepressants, clomipramine, FKBP51, SUMOylation, glucocorticoid receptor, PIAS4, HSP90, FKBP52, glucocorticoid resistance, stress-related disorders, astrocytes, antidepressant mechanism
MeSH terms
Animals, Antidepressive Agents, Tricyclic, Clomipramine, Gene Expression Regulation, Receptors, Glucocorticoid, Tacrolimus Binding Proteins, Mice, Rats, Sumoylation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity. https://app.cochat.ai/papers/10.1038/s41380-022-01491-0
The paper
Budziñski, M. L., Sokn, C., Gobbini, R., Ugo, B., Antunica-Noguerol, M., Senin, S., Bajaj, T., Gassen, N. C., Rein, T., Schmidt, M. V., Binder, E. B., Arzt, E., & Liberman, A. C. (2022). Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01491-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.